Oncology Institute, Inc. Quarterly Common Stock, Shares Authorized from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Oncology Institute, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2018 to Q3 2024.
  • Oncology Institute, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 500M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 500M 0 0% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 500M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 500M 0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 500M 0 0% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 500M 0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 500M 0 0% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 500M 0 0% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 500M 0 0% Dec 31, 2022 10-K 2024-03-28
Q3 2022 500M 0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 500M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 500M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 500M Dec 31, 2021 10-K 2023-03-16
Q3 2021 500M +100M +25% Nov 12, 2021 10-K 2023-03-16
Q3 2020 400M Nov 6, 2020 10-K 2022-03-11
Q3 2018 20K* Sep 10, 2018 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.